ArticleJournal of functional biomaterials2026
Plasma Treatment Enhances Cytocompatibility on Patterned Perfluoroethylene Propylene.
Article in Journal of functional biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study aims to construct patterns with defined shapes on perfluoroethylene propylene (FEP) via a replication process that has potential applications in tissue engineering. Our focus was on creating ripple periodic submicron-scale structures and subsequently activating them with argon plasma. Plasma activation of the replicated pattern on FEP substrates proved to be an effective, easy-to-execute and cost-efficient treatment method. Structured and activated carriers were prepared to study targeted cell growth in terms of cell adhesion and proliferation. Furthermore, the carriers were used to influence cell shape and the direction of the cell growth based on the properties of the pattern, primarily its morphology and dimensions. The carriers were seeded with human Wharton's jelly stromal cells and their metabolic activity and morphology were studied using a resazurin assay and fluorescence staining of the actin cytoskeleton and cell nuclei. We found that plasma treatment improves cell adhesion of the material more effectively than patterning the material with submicron-scale grooves (approximately 500 nm wide). However, this patterning enhances the susceptibility of the material to plasma modification, as evidenced by the subsequent improvement in cell growth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.